世界各国のリアルタイムなデータ・インテリジェンスで皆様をお手伝い

細胞表面マーカーの世界市場 2022-2026年

細胞表面マーカーの世界市場 2022-2026年


Global Cell Surface Markers Market 2022-2026

世界の細胞表面マーカー市場 2022-2026年 Technavio社は、細胞表面マーカー市場をモニターしており、予測期間中に7.40%のCAGRで減速しながら、2022年から2026年にかけて100億ドルの成長が見込まれています。当レ... もっと見る

　

　

出版社 出版年月 電子版価格 納期 ページ数 言語
TechNavio
テクナビオ 		2021年12月6日 US$2,500
シングルユーザーライセンス
ライセンス・価格情報
注文方法はこちら 		2営業日程度 120 英語

日本語のページは自動翻訳を利用し作成しています。


　

サマリー

世界の細胞表面マーカー市場 2022-2026年
Technavio社は、細胞表面マーカー市場をモニターしており、予測期間中に7.40%のCAGRで減速しながら、2022年から2026年にかけて100億ドルの成長が見込まれています。当レポートでは、細胞表面マーカー市場について、全体的な分析、市場規模と予測、トレンド、成長要因、課題に加えて、約25社のベンダーを対象としたベンダー分析を行っています。
本レポートでは、現在の世界市場のシナリオ、最新のトレンドとドライバー、そして市場全体の環境に関する最新の分析を提供しています。市場を牽引しているのは、COVID-19のパンデミックによる影響と、革新的で効果的な細胞表面マーカーの登場です。さらに、COVID-19パンデミックの影響は、市場の成長をも押し上げると予想されています。
細胞表面マーカー市場の分析には、アプリケーションセグメントと地理的状況が含まれています。
Technavioの細胞表面マーカー市場は以下のように区分されています。
アプリケーション別
- 疾病診断
- 研究・創薬
地理的ランドスケープ別
- 北アメリカ
- ヨーロッパ
- アジア
- ROW
本調査では、効果的な医薬品を発売するための研究開発への投資が増加していることが、今後数年間の細胞表面マーカー市場の成長を促進する主な理由の一つであると分析しています。
Technavio社は、複数の情報源から得たデータを調査、合成、主要なパラメータの分析によってまとめ、市場の詳細な情報を提供しています。本レポートでは、細胞表面マーカー市場について以下の領域をカバーしています。
- 細胞表面マーカー市場のサイジング
- 細胞表面マーカー市場の予測
- 細胞表面マーカー市場の産業分析
Technavioの堅牢なベンダー分析は、クライアントの市場での地位向上を支援することを目的としています。これに沿って、本レポートでは、細胞表面マーカー市場の主要ベンダーであるAbbott Laboratories、Becton Dickinson and Co.、Bio Rad Laboratories Inc.、Danaher Corp.、DiaSorin SpA、F. Hoffmann-La Roche Ltd.、Grifols SA、QIAGEN NV、Siemens Healthineers AG、Thermo Fisher Scientific Inc.などの詳細な分析を行っています。また、細胞表面マーカー市場の分析レポートには、市場成長に影響を与える今後のトレンドや課題に関する情報も含まれています。これは、企業が戦略を立て、来るべきすべての成長機会を活用するのに役立つものです。
本調査は、業界の主要参加者からの情報を含む一次情報と二次情報を客観的に組み合わせて実施しました。本レポートには、主要ベンダーの分析に加えて、包括的な市場およびベンダーランドスケープが含まれています。このレポートの詳細については、- https://www.technavio.com/report/cell-surface-markers-market-industry-analysis をご覧ください。
Technavio社は、複数の情報源から得たデータを調査、合成、要約し、利益、価格、競争、プロモーションなどの主要なパラメーターを分析することで、市場の詳細なイメージを提示しています。また、業界の主要なインフルエンサーを特定することで、様々な市場の側面を提示しています。提示されたデータは包括的で信頼性が高く、一次および二次両方の広範な調査の結果です。Technavio社の市場調査レポートは、正確な市場成長を予測するために、完全な競合状況と、質的および量的調査を用いた詳細なベンダー選択方法と分析を提供しています。

ページTOPに戻る


目次

• Executive Summary
o Market Overview
• Market Landscape
o Market ecosystem
o Value chain analysis
• Market Sizing
o Market definition
o Market segment analysis
o Market size 2021
o Market outlook: Forecast for 2021 - 2026
• Five Forces Analysis
o Bargaining power of buyers
o Bargaining power of suppliers
o Threat of new entrants
o Threat of substitutes
o Threat of rivalry
o Market condition
• Market Segmentation by Application
o Market segments
o Comparison by Application
o Disease diagnosis - Market size and forecast 2021-2026
o Research and drug discovery - Market size and forecast 2021-2026
o Market opportunity by Application
• Customer landscape
• Geographic Landscape
o Geographic segmentation
o Geographic comparison
o North America - Market size and forecast 2021-2026
o Europe - Market size and forecast 2021-2026
o Asia - Market size and forecast 2021-2026
o ROW - Market size and forecast 2021-2026
o Key leading countries
o Market opportunity By Geographical Landscape
o Market drivers
o Market challenges
o Market trends
• Vendor Landscape
o Landscape disruption
• Vendor Analysis
o Vendors covered
o Market positioning of vendors
o Abbott Laboratories
o Becton Dickinson and Co.
o Bio Rad Laboratories Inc.
o Danaher Corp.
o DiaSorin SpA
o F. Hoffmann-La Roche Ltd.
o Grifols SA
o QIAGEN NV
o Siemens Healthineers AG
o Thermo Fisher Scientific Inc.
• Appendix
o Scope of the report
o Currency conversion rates for US$
o Research methodology
o List of abbreviations

Exhibits
• 1: Key Finding 1
• 2: Key Finding 2
• 3: Key Finding 3
• 4: Key Finding 5
• 5: Key Finding 6
• 6: Key Finding 7
• 7: Key Finding 8
• 8: Parent market
• 9: Market characteristics
• 10: Offerings of vendors included in the market definition
• 11: Market segments
• 12: Global - Market size and forecast 2021 - 2026 ($ billion)
• 13: Global market: Year-over-year growth 2021 - 2026 (%)
• 14: Five forces analysis 2021 & 2026
• 15: Bargaining power of buyers
• 16: Bargaining power of suppliers
• 17: Threat of new entrants
• 18: Threat of substitutes
• 19: Threat of rivalry
• 20: Market condition - Five forces 2021
• 21: Application - Market share 2021-2026 (%)
• 22: Comparison by Application
• 23: Disease diagnosis - Market size and forecast 2021-2026 ($ billion)
• 24: Disease diagnosis - Year-over-year growth 2021-2026 (%)
• 25: Research and drug discovery - Market size and forecast 2021-2026 ($ billion)
• 26: Research and drug discovery - Year-over-year growth 2021-2026 (%)
• 27: Market opportunity by Application
• 28: Customer landscape
• 29: Market share By Geographical Landscape 2021-2026 (%)
• 30: Geographic comparison
• 31: North America - Market size and forecast 2021-2026 ($ billion)
• 32: North America - Year-over-year growth 2021-2026 (%)
• 33: Europe - Market size and forecast 2021-2026 ($ billion)
• 34: Europe - Year-over-year growth 2021-2026 (%)
• 35: Asia - Market size and forecast 2021-2026 ($ billion)
• 36: Asia - Year-over-year growth 2021-2026 (%)
• 37: ROW - Market size and forecast 2021-2026 ($ billion)
• 38: ROW - Year-over-year growth 2021-2026 (%)
• 39: Key leading countries
• 40: Market opportunity By Geographical Landscape ($ billion)
• 41: Impact of drivers and challenges
• 42: Vendor landscape
• 43: Landscape disruption
• 44: Industry risks
• 45: Vendors covered
• 46: Market positioning of vendors
• 47: Abbott Laboratories - Overview
• 48: Abbott Laboratories - Business segments
• 49: Abbott Laboratories - Key offerings
• 50: Abbott Laboratories - Key customers
• 51: Abbott Laboratories - Segment focus
• 52: Becton Dickinson and Co. - Overview
• 53: Becton Dickinson and Co. - Business segments
• 54: Becton Dickinson and Co. - Key offerings
• 55: Becton Dickinson and Co. - Key customers
• 56: Becton Dickinson and Co. - Segment focus
• 57: Bio Rad Laboratories Inc. - Overview
• 58: Bio Rad Laboratories Inc. - Business segments
• 59: Bio Rad Laboratories Inc. - Key offerings
• 60: Bio Rad Laboratories Inc. - Key customers
• 61: Bio Rad Laboratories Inc. - Segment focus
• 62: Danaher Corp. - Overview
• 63: Danaher Corp. - Business segments
• 64: Danaher Corp. - Key offerings
• 65: Danaher Corp. - Key customers
• 66: Danaher Corp. - Segment focus
• 67: DiaSorin SpA - Overview
• 68: DiaSorin SpA - Business segments
• 69: DiaSorin SpA - Key offerings
• 70: DiaSorin SpA - Key customers
• 71: DiaSorin SpA - Segment focus
• 72: F. Hoffmann-La Roche Ltd. - Overview
• 73: F. Hoffmann-La Roche Ltd. - Business segments
• 74: F. Hoffmann-La Roche Ltd. - Key offerings
• 75: F. Hoffmann-La Roche Ltd. - Key customers
• 76: F. Hoffmann-La Roche Ltd. - Segment focus
• 77: Grifols SA - Overview
• 78: Grifols SA - Business segments
• 79: Grifols SA - Key offerings
• 80: Grifols SA - Key customers
• 81: Grifols SA - Segment focus
• 82: QIAGEN NV - Overview
• 83: QIAGEN NV - Business segments
• 84: QIAGEN NV - Key offerings
• 85: QIAGEN NV - Key customers
• 86: QIAGEN NV - Segment focus
• 87: Siemens Healthineers AG - Overview
• 88: Siemens Healthineers AG - Business segments
• 89: Siemens Healthineers AG - Key offerings
• 90: Siemens Healthineers AG - Key customers
• 91: Siemens Healthineers AG - Segment focus
• 92: Thermo Fisher Scientific Inc. - Overview
• 93: Thermo Fisher Scientific Inc. - Business segments
• 94: Thermo Fisher Scientific Inc. - Key offerings
• 95: Thermo Fisher Scientific Inc. - Key customers
• 96: Thermo Fisher Scientific Inc. - Segment focus
• 97: Currency conversion rates for US$
• 98: Research Methodology
• 99: Validation techniques employed for market sizing
• 100: Information sources
• 101: List of abbreviations

　

ページTOPに戻る


　

Summary

Global Cell Surface Markers Market 2022-2026
Technavio has been monitoring the cell surface markers market and it is poised to grow by $ 10.00 bn during 2022-2026, decelerating at a CAGR of 7.40% during the forecast period. Our report on the cell surface markers market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.
The report offers an up-to-date analysis regarding the current global market scenario, latest trends and drivers, and the overall market environment. The market is driven by the COVID-19 pandemic impact and the introduction of innovative and effective cell surface markers. In addition, the COVID-19 pandemic impact is anticipated to boost the growth of the market as well.
The cell surface markers market analysis includes the application segment and geographic landscape.
Technavio's cell surface markers market is segmented as below:
By Application
• Disease diagnosis
• Research and drug discovery
By Geographical Landscape
• North America
• Europe
• Asia
• ROW
This study identifies the higher investment in R&D for launch of effective drugsas one of the prime reasons driving the cell surface markers market growth during the next few years.
Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters. Our report on cell surface markers market covers the following areas:
• Cell surface markers market sizing
• Cell surface markers market forecast
• Cell surface markers market industry analysis
Technavio's robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading cell surface markers market vendors that include Abbott Laboratories, Becton Dickinson and Co., Bio Rad Laboratories Inc., Danaher Corp., DiaSorin SpA, F. Hoffmann-La Roche Ltd., Grifols SA, QIAGEN NV, Siemens Healthineers AG, and Thermo Fisher Scientific Inc. Also, the cell surface markers market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors. For further information on this report, please visit - https://www.technavio.com/report/cell-surface-markers-market-industry-analysis
Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. Technavio's market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.



ページTOPに戻る


Table of Contents

• Executive Summary
o Market Overview
• Market Landscape
o Market ecosystem
o Value chain analysis
• Market Sizing
o Market definition
o Market segment analysis
o Market size 2021
o Market outlook: Forecast for 2021 - 2026
• Five Forces Analysis
o Bargaining power of buyers
o Bargaining power of suppliers
o Threat of new entrants
o Threat of substitutes
o Threat of rivalry
o Market condition
• Market Segmentation by Application
o Market segments
o Comparison by Application
o Disease diagnosis - Market size and forecast 2021-2026
o Research and drug discovery - Market size and forecast 2021-2026
o Market opportunity by Application
• Customer landscape
• Geographic Landscape
o Geographic segmentation
o Geographic comparison
o North America - Market size and forecast 2021-2026
o Europe - Market size and forecast 2021-2026
o Asia - Market size and forecast 2021-2026
o ROW - Market size and forecast 2021-2026
o Key leading countries
o Market opportunity By Geographical Landscape
o Market drivers
o Market challenges
o Market trends
• Vendor Landscape
o Landscape disruption
• Vendor Analysis
o Vendors covered
o Market positioning of vendors
o Abbott Laboratories
o Becton Dickinson and Co.
o Bio Rad Laboratories Inc.
o Danaher Corp.
o DiaSorin SpA
o F. Hoffmann-La Roche Ltd.
o Grifols SA
o QIAGEN NV
o Siemens Healthineers AG
o Thermo Fisher Scientific Inc.
• Appendix
o Scope of the report
o Currency conversion rates for US$
o Research methodology
o List of abbreviations

Exhibits
• 1: Key Finding 1
• 2: Key Finding 2
• 3: Key Finding 3
• 4: Key Finding 5
• 5: Key Finding 6
• 6: Key Finding 7
• 7: Key Finding 8
• 8: Parent market
• 9: Market characteristics
• 10: Offerings of vendors included in the market definition
• 11: Market segments
• 12: Global - Market size and forecast 2021 - 2026 ($ billion)
• 13: Global market: Year-over-year growth 2021 - 2026 (%)
• 14: Five forces analysis 2021 & 2026
• 15: Bargaining power of buyers
• 16: Bargaining power of suppliers
• 17: Threat of new entrants
• 18: Threat of substitutes
• 19: Threat of rivalry
• 20: Market condition - Five forces 2021
• 21: Application - Market share 2021-2026 (%)
• 22: Comparison by Application
• 23: Disease diagnosis - Market size and forecast 2021-2026 ($ billion)
• 24: Disease diagnosis - Year-over-year growth 2021-2026 (%)
• 25: Research and drug discovery - Market size and forecast 2021-2026 ($ billion)
• 26: Research and drug discovery - Year-over-year growth 2021-2026 (%)
• 27: Market opportunity by Application
• 28: Customer landscape
• 29: Market share By Geographical Landscape 2021-2026 (%)
• 30: Geographic comparison
• 31: North America - Market size and forecast 2021-2026 ($ billion)
• 32: North America - Year-over-year growth 2021-2026 (%)
• 33: Europe - Market size and forecast 2021-2026 ($ billion)
• 34: Europe - Year-over-year growth 2021-2026 (%)
• 35: Asia - Market size and forecast 2021-2026 ($ billion)
• 36: Asia - Year-over-year growth 2021-2026 (%)
• 37: ROW - Market size and forecast 2021-2026 ($ billion)
• 38: ROW - Year-over-year growth 2021-2026 (%)
• 39: Key leading countries
• 40: Market opportunity By Geographical Landscape ($ billion)
• 41: Impact of drivers and challenges
• 42: Vendor landscape
• 43: Landscape disruption
• 44: Industry risks
• 45: Vendors covered
• 46: Market positioning of vendors
• 47: Abbott Laboratories - Overview
• 48: Abbott Laboratories - Business segments
• 49: Abbott Laboratories - Key offerings
• 50: Abbott Laboratories - Key customers
• 51: Abbott Laboratories - Segment focus
• 52: Becton Dickinson and Co. - Overview
• 53: Becton Dickinson and Co. - Business segments
• 54: Becton Dickinson and Co. - Key offerings
• 55: Becton Dickinson and Co. - Key customers
• 56: Becton Dickinson and Co. - Segment focus
• 57: Bio Rad Laboratories Inc. - Overview
• 58: Bio Rad Laboratories Inc. - Business segments
• 59: Bio Rad Laboratories Inc. - Key offerings
• 60: Bio Rad Laboratories Inc. - Key customers
• 61: Bio Rad Laboratories Inc. - Segment focus
• 62: Danaher Corp. - Overview
• 63: Danaher Corp. - Business segments
• 64: Danaher Corp. - Key offerings
• 65: Danaher Corp. - Key customers
• 66: Danaher Corp. - Segment focus
• 67: DiaSorin SpA - Overview
• 68: DiaSorin SpA - Business segments
• 69: DiaSorin SpA - Key offerings
• 70: DiaSorin SpA - Key customers
• 71: DiaSorin SpA - Segment focus
• 72: F. Hoffmann-La Roche Ltd. - Overview
• 73: F. Hoffmann-La Roche Ltd. - Business segments
• 74: F. Hoffmann-La Roche Ltd. - Key offerings
• 75: F. Hoffmann-La Roche Ltd. - Key customers
• 76: F. Hoffmann-La Roche Ltd. - Segment focus
• 77: Grifols SA - Overview
• 78: Grifols SA - Business segments
• 79: Grifols SA - Key offerings
• 80: Grifols SA - Key customers
• 81: Grifols SA - Segment focus
• 82: QIAGEN NV - Overview
• 83: QIAGEN NV - Business segments
• 84: QIAGEN NV - Key offerings
• 85: QIAGEN NV - Key customers
• 86: QIAGEN NV - Segment focus
• 87: Siemens Healthineers AG - Overview
• 88: Siemens Healthineers AG - Business segments
• 89: Siemens Healthineers AG - Key offerings
• 90: Siemens Healthineers AG - Key customers
• 91: Siemens Healthineers AG - Segment focus
• 92: Thermo Fisher Scientific Inc. - Overview
• 93: Thermo Fisher Scientific Inc. - Business segments
• 94: Thermo Fisher Scientific Inc. - Key offerings
• 95: Thermo Fisher Scientific Inc. - Key customers
• 96: Thermo Fisher Scientific Inc. - Segment focus
• 97: Currency conversion rates for US$
• 98: Research Methodology
• 99: Validation techniques employed for market sizing
• 100: Information sources
• 101: List of abbreviations

　

ページTOPに戻る

ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

webからのご注文・お問合せはこちらのフォームから承ります

本レポートと同分野の最新刊レポート

  • 本レポートと同分野の最新刊レポートはありません。

TechNavio社の